Suchergebnisse - "Xia, Zhongjun"

PubPharm (35)

1

Global miRNA profiling reveals key molecules that contribute to different chronic lymphocytic leukemia incidences in Asian and Western populations

enthalten in: Haematologica | 2024

von Liu, P. | Wang, K. | Li, J. | +6

2

Chinese expert consensus on the management of patients with hematologic malignancies infected with SARS-CoV-2

enthalten in: Journal of cancer research and therapeutics | 2023

von Wang, J. | Shao, L. | Liang, J. | +46

3

Targeting P21-activated kinase suppresses proliferation and enhances chemosensitivity in T-cell lymphoblastic lymphoma

enthalten in: Blood science (Baltimore, Md.) | 2023

von Su, N. | Fang, Y. | Chen, X. | +7

4

Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301) : a randomised, double-blinded, placebo-controlled, phase 3 trial

enthalten in: BMC cancer | 2023

von Xia, Z. | Leng, Y. | Fang, B. | +51

5

Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients : Multi-center, single-arm, open-label, phase 2 study

enthalten in: American journal of hematology | 2023

von Xu, W. | Zhou, K. | Wang, T. | +22

6

Current treatment paradigm and survival outcomes among patients with newly diagnosed multiple myeloma in China : a retrospective multicenter study

enthalten in: Cancer biology & medicine | 2023

von Fan, H. | Wang, W. | Zhang, Y. | +6

7

Chinese expert consensus on intestinal microecology and management of digestive tract complications related to tumor treatment (version 2022)

enthalten in: Journal of cancer research and therapeutics | 2022

von Wang, J. | Liang, J. | He, M. | +37

8

Ibrutinib as monotherapy versus combination therapy in Chinese patients with relapsed/refractory mantle cell lymphoma : A multicenter study

enthalten in: Cancer medicine | 2022

von Zhang, Y. | Liu, P. | Cai, J. | +19

9

Malignant clonal evolution drives multiple myeloma cellular ecological diversity and microenvironment reprogramming

enthalten in: Molecular cancer | 2022

von Liang, Y. | He, H. | Wang, W. | +7

10

Efficacy and safety comparison between R-CHOP and modified NHL-BFM-90 regimens in children and adolescents with diffuse large B-cell lymphoma

enthalten in: Annals of hematology | 2022

von Guan, J. | Sun, F. | Wang, J. | +11